Whether it’s the classic luxury of Champagne and caviar, a narrative-driven wine and tasting menu, a sake and small bites ...

Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His had a long list, unfortunately closed by his passing away at the age of 92 ...

(Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has received a minimum ...

Abstract: Multiple programming tasks require synchronous collaboration between developers, giving rise to real-time collaborative programming tools that enable ...

Ingo Swann participated in classified experiments involving remote viewing. According to his account, he observed structures on the Moon. Watch the discovery that turned Mars from dead to disturbing ...

See how Arizona lets investors own law firms In almost every U.S. state, people who aren't lawyers can't own a law firm. Through Arizona’s “Alternative Business Structures” program, you can.

An Arizona Supreme Court program allowing nonlawyers to own law firms has led to numerous consumer complaints. Several members of the program's oversight committee also have financial ties to firms ...

Commercial Property Assessed Clean Energy (C-PACE) is evolving. Driven by growing deal sizes and innovative structuring, C-PACE is emerging as a foundational, primary source of funding for the ...

“Multiscale Structural Mechanics: Top-Down Modeling of Composite Structures Using Mechanics of Structure Genome” delivers a unified approach to composites modeling based on the concept of structure ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...